The relationship of sputum eosinophilia and sputum cell generation of IL-5.

BACKGROUND Eosinophil recruitment to the airway after antigen challenge is regulated by many factors, including airway cell generation of cytokines. OBJECTIVES The purpose of this study was to determine the relationship between sputum cell generation of IL-5 and the appearance of eosinophils in the sputum after antigen challenge. METHODS Sputum samples from 11 allergic subjects were collected before and again 4 and 24 hours after antigen challenge. In 6 of these subjects, induced sputum samples were also obtained 48 hours and 7 days after challenge. Sputum leukocyte differential and cell counts and eosinophil-derived neurotoxin levels were determined. Sputum cells were then cultured with PHA (10 microg/mL) to stimulate IL-5 and IFN-gamma, which were measured in culture supernatants. RESULTS An increase in sputum eosinophils and eosinophil-derived neurotoxin levels was detected at 4 hours after antigen challenge, with peak values at 24 hours. In contrast, significant increases in ex vivo generation of IL-5 by sputum cells was not seen until 24 hours after challenge. At 24 hours, PHA-induced IL-5 correlated with airspace eosinophil values (r (s) = 0.78, P <.01). In addition, the ratio of IFN-gamma/IL-5 decreased at 24 hours (P <.05) and had an inverse correlation with sputum eosinophils (r (s)= -0.68, P <.05). CONCLUSION Although eosinophils are increased in the airway lumen as early as 4 hours, the ex vivo generation of IL-5 by sputum cells is first noted in samples obtained 24 hours after antigen challenge. This suggests that the early (4 hours) recruitment of eosinophils to the airway lumen may be regulated by factors other than IL-5 or that mucosal cells (rather than airspace cells) contribute to the IL-5 generation at this time point. Furthermore, IL-5 generation by airspace cells may be more responsible for either eosinophil recruitment or retention at later time points.

[1]  P. Foster,et al.  The Effect of IL-5 and Eotaxin Expression in the Lung on Eosinophil Trafficking and Degranulation and the Induction of Bronchial Hyperreactivity1 , 2000, The Journal of Immunology.

[2]  K. Chung,et al.  Neutrophilic inflammation in severe persistent asthma. , 1999, American journal of respiratory and critical care medicine.

[3]  P. O'Byrne,et al.  Kinetics of allergen-induced airway eosinophilic cytokine production and airway inflammation. , 1999, American journal of respiratory and critical care medicine.

[4]  I. Pavord,et al.  Increases in eotaxin‐positive cells in induced sputum from atopic asthmatic subjects after inhalational allergen challenge , 1999, Allergy.

[5]  M. Lampinen,et al.  The role of interleukin‐5, interleukin‐8 and RANTES in the chemotactic attraction of eosinophils to the allergic lung , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[6]  E. Minshall,et al.  Eotaxin and monocyte chemotactic protein-4 mRNA expression in small airways of asthmatic and nonasthmatic individuals. , 1999, The Journal of allergy and clinical immunology.

[7]  E. Minshall,et al.  IL-4 and IL-5 mRNA expression in induced sputum of asthmatic subjects: comparison with bronchial wash. , 1999, The Journal of allergy and clinical immunology.

[8]  W. Busse,et al.  Segmental antigen challenge increases fibronectin in bronchoalveolar lavage fluid. , 1999, American journal of respiratory and critical care medicine.

[9]  P. O'Byrne,et al.  Increases in airway eosinophils and interleukin-5 with minimal bronchoconstriction during repeated low-dose allergen challenge in atopic asthmatics. , 1998, The European respiratory journal.

[10]  H. Xu,et al.  Effect of inhaled interleukin-5 on airway hyperreactivity and eosinophilia in asthmatics. , 1998, American journal of respiratory and critical care medicine.

[11]  W. Busse,et al.  The effect of segmental bronchoprovocation with allergen on airway lymphocyte function. , 1997, American journal of respiratory and critical care medicine.

[12]  Q. Hamid,et al.  Increased expression of eotaxin in bronchoalveolar lavage and airways of asthmatics contributes to the chemotaxis of eosinophils to the site of inflammation. , 1997, Journal of immunology.

[13]  F. Hargreave,et al.  Sputum in severe exacerbations of asthma: kinetics of inflammatory indices after prednisone treatment. , 1997, American journal of respiratory and critical care medicine.

[14]  W. Busse,et al.  The immediate and late allergic response to segmental bronchopulmonary provocation in asthma. , 1997, American journal of respiratory and critical care medicine.

[15]  P. Barnes,et al.  Late response to allergen is associated with increased concentrations of tumor necrosis factor-alpha and IL-5 in induced sputum. , 1997, The Journal of allergy and clinical immunology.

[16]  P. Foster,et al.  Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. , 1997, The Journal of clinical investigation.

[17]  F. Hargreave,et al.  Indices of airway inflammation in induced sputum: reproducibility and validity of cell and fluid-phase measurements. , 1996, American journal of respiratory and critical care medicine.

[18]  H. Kita,et al.  Eosinophil recruitment is associated with IL-5, but not with RANTES, twenty-four hours after allergen challenge. , 1996, The Journal of allergy and clinical immunology.

[19]  B. Dewald,et al.  Monocyte chemotactic protein 4 (MCP-4), a novel structural and functional analogue of MCP-3 and eotaxin , 1996, The Journal of experimental medicine.

[20]  K. Asano,et al.  Cytokine concentrations in sputum of asthmatic patients. , 1996, International archives of allergy and immunology.

[21]  R. Egan,et al.  Effects of an antibody to interleukin-5 in a monkey model of asthma. , 1995, American journal of respiratory and critical care medicine.

[22]  H. Boushey,et al.  Cellular and biochemical analysis of induced sputum from asthmatic and from healthy subjects. , 1993, The American review of respiratory disease.

[23]  P. Forsythe,et al.  RANTES is a chemotactic and activating factor for human eosinophils. , 1993, Journal of immunology.

[24]  W. Busse,et al.  IL-5 is the predominant eosinophil-active cytokine in the antigen-induced pulmonary late-phase reaction. , 1993, The American review of respiratory disease.

[25]  I. van Ark,et al.  Effect of anti-IL-5 and IL-5 on airway hyperreactivity and eosinophils in guinea pigs. , 1993, The American review of respiratory disease.

[26]  R. Schweizer,et al.  Modulation of eosinophil chemotaxis by interleukin-5. , 1992, American journal of respiratory cell and molecular biology.

[27]  S. Durham,et al.  Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. , 1992, The New England journal of medicine.

[28]  W. Busse,et al.  Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. , 1991, The American review of respiratory disease.

[29]  V. Brusasco,et al.  Late-phase asthmatic reaction to inhaled allergen is associated with early recruitment of eosinophils in the airways. , 1991, The American review of respiratory disease.

[30]  R. Kyle,et al.  IgA-induced eosinophil degranulation. , 1989, Journal of immunology.